Ozempic vs Semaglutide: What's the Difference?
Short answer: they're the same molecule. The confusion is about branding, dosing, and FDA-approved indications.
Same Drug, Different Labels
Semaglutide is the active pharmaceutical ingredient. Ozempic, Wegovy, and Rybelsus are all brand names manufactured by Novo Nordisk, each approved for different uses:
Ozempic: FDA-approved for type 2 diabetes management. Max dose 2.0mg/week. Covered by most diabetes-related insurance plans.
Wegovy: FDA-approved for chronic weight management. Higher max dose (2.4mg/week). Insurance coverage is inconsistent for weight loss indications.
Rybelsus: Oral semaglutide tablet. Approved for type 2 diabetes. Lower bioavailability than injectable forms.
Compounded semaglutide: Made by licensed compounding pharmacies. Same active ingredient. Prescribed by telehealth licensed weight loss providerss like Heyday for weight management at a fraction of the brand-name cost.
Why People Use "Ozempic" for Weight Loss
Ozempic is the most recognized brand name, so "Ozempic for weight loss" became the default search term — even though Wegovy is the FDA-approved weight loss formulation. Many providers prescribe Ozempic off-label for weight management, or use compounded semaglutide through Heyday semaglutide which is pharmacologically identical at a lower cost.
Does the Brand Matter?
From a molecular standpoint, semaglutide is semaglutide regardless of the label. What matters is the dose, the injection schedule, and medical oversight — not whether the box says Ozempic, Wegovy, or comes from a compounding pharmacy. A licensed provider adjusts your dose based on your response, not the brand name.
What Heyday Prescribes
Heyday providers prescribe compounded semaglutide for eligible patients — the same active molecule at therapeutic doses, sourced from licensed U.S. pharmacies, at a price point ($299/month) that makes treatment accessible without insurance dependency.